Purpose: To evaluate the utility of two-dimensional (2D) Localized Correlated Spectroscopy (L-COSY) in metabolic profiling of the human brain at 7 Tesla (T).
THE ADVENT OF high field clinical MRI magnets, with field strengths of 7 Tesla (T) and above (1), promises linear increases in sensitivity and spectral resolution for in vivo MR spectroscopy (MRS). The improved sensitivity at 7T permits detection of lowconcentration metabolites whose signal may be too weak to distinguish from background noise at lower fields, while increased chemical shift dispersion facilitates improved spectral separation of metabolites with similar chemical shifts on conventional onedimensional (1D) MRS. Previous human brain 1D MRS studies at 7T with short echo time (TE) sequences have reported detection of a broad range of metabolites, including gamma-aminobutyric acid (GABA), glutamate (Glu), glutamine (Gln), glutathione (GSH), myo-inositol (mI), and phosphocholine (PC) (2) (3) (4) . However, these peaks are subject to severe spectral overlap in 1D MRS due to their complex multiplet patterns and the presence of overlapping resonances.
In vivo two-dimensional (2D) MRS techniques (5,6), such as localized correlated spectroscopy (L-COSY), aid in further improving the metabolic characterization of the brain compared with 1D analogues (7, 8) . By adding a second spectral dimension through the indirect monitoring of t 1 evolution, 2D L-COSY detects the transfer of coherence between J-coupled metabolites. Coherence transfer manifests as "cross-peaks" in the 2D spectrum and helps facilitate the unambiguous assignment of metabolites whose primary resonances-"diagonal peaks" in the 2D spectrum-may otherwise appear co-resonant with other metabolites similar to that of 1D MRS. The 2D L-COSY sequence has been successfully implemented on the 1.5T and 3T MRI scanners to study the human brain (9) (10) (11) . More recently, the 2D L-COSY sequence has also been implemented at 7T with specific applications described in soleus muscle (12) .
The primary focus of this study was to implement 2D L-COSY on the 7T MRI scanner, and to assess its reliability in measuring cerebral metabolites in humans, particularly of those that are more difficult to characterize at lower field strengths. Figure 1 shows the pulse sequence diagram for the 2D L-COSY sequence that was implemented on the 7T scanner. The 2D L-COSY sequence used a modified point resolved spectroscopic sequence (PRESS) (13) localization scheme consisting of 90 -180 -90 slice selective radiofrequency (RF) pulses, where the last pulse was changed from a refocusing 180 to a 90 pulse which facilitated the coherence transfer necessary for correlating the J-coupled metabolite peaks in the second dimension. The resulting coherence transfer echo was read out using the analog-to-digital converter (ADC). An incremental Dt 1 delay was introduced between the 180 and final 90 pulses to indirectly sample the t 1 dimension. Uncoupled spins do not experience any coherence transfer and consequently maintain equal intensity during t 1 evolution and readout periods (t 2 ). These spins appear along the diagonal in the Fourier transformed spectrum. The coupled spins between which coherence transfer occurs during the t 1 evolution period exhibit different F 1 and F 2 frequencies and appear off the main diagonal as cross-peaks in the 2D spectrum after a double Fourier transformation. The Dt 1 increment used in the 7T studies was 0.4 ms resulting in a bandwidth of 2500 Hz along the indirect dimension (F 1 ). Increased dielectric effects at higher fields result in increased B 1 field inhomogeneity (14) , and thus the resulting inconsistent excitation profiles are a greater concern at 7T. The vendor-provided FASTESTMAP shimming method (Siemens Medical Solutions, Erlangen, Germany) was used to minimize spectral linewidths (15, 16) . To counteract shorter T 2 relaxation times at 7T (17) (18) (19) , pulse lengths, gradient duration, and interpulse delays were reduced to a minimum, resulting in a TE of 18 ms, while maintaining desired gradient crusher durations and RF pulse shapes. The 180 RF pulse duration was 4.4 ms and associated crusher duration was 1.0 ms. The 90 coherence transfer pulse had a duration of 2.4 ms and crusher duration of 1.5 ms.
MATERIALS AND METHODS

Pulse Sequence
The bandwidth of the 180 RF pulse was restricted to 1200 Hz (4.0 ppm) and was centered at 2.35 ppm, which resulted in a more uniform excitation profile while preserving signal quality across most of the spectrum of interest. These bandwidth-limited pulses resulted in slightly reduced excitation of water at 4.7 ppm and the 0.0 ppm resonance of the 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) used in the phantom studies. Because both the 90 RF and coherence transfer pulses had bandwidths of 2400 Hz (8.1 ppm), and the coherence transfer pulse in particular is responsible for generating the cross-peaks, the ratio between cross-peak and diagonal peak intensities is not affected by the bandwidth limitations. The refocusing pulse does not distort the cross-peak signals because coherence transfer is a nonlinear process in time and not reversible with a simple 180 RF. To further confirm the effect of lower bandwidth on measured metabolite ratios, a phantom study was conducted implementing RF pulse bandwidths ranging from 900 Hz to 2400 Hz, in intervals of 300 Hz. It was found that for signals near or inside the range of 0.65 ppm and 4.35 ppm, which includes all the metabolites quantified in this study, the metabolite to Cr ratio changed by less than 10% on average (data not shown).
Water suppression was performed using the variable pulse power and optimized relaxation delays (VAPOR) sequence (20) , which implements seven RF pulses to reduce sensitivity to variations in the B 1 field. The scans were performed on Siemens 7T and 3T Tim-Trio whole-body MRI/MRS scanners (Siemens Medical Solutions, Erlangen, Germany) both operating on the VB17A platform. The 32-channel receive/volume transmit head coils were used to acquire all data for these studies.
Phantom Studies
Initial testing of the 2D L-COSY sequence was conducted using a "brain" phantom containing 16 metabolites at physiological concentrations (21) (22) (23) . Table 1 lists these metabolites along with their chemical shifts and concentrations. The DF 1 and DF 2 values represent the range in frequency covered by the quantification region around the chemical shift of each peak. The bottom of Table 1 shows metabolites found in the human brain but which were not present in the phantom. Some metabolites appear multiple times in the table, indicating different cross-peaks that were each measured separately. For example, the cross-peak identified as "mIþCho" represents the combined cross-peak of myo-Inositol (mI) and free choline (Cho) and this was measured separately from "mI" which is a cross-peak originating from myo-Inositol alone. Repeatability (test-retest) studies were performed by acquiring 30 L-COSY spectra from the phantom over 3 nonconsecutive days. Scan parameters for all The same brain phantom was also scanned 27 times over three nonconsecutive days using a Siemens Tim-Trio 3T whole-body scanner, to facilitate a signal quality comparison between the two field strengths. F 2 and F 1 bandwidths were halved to 2000 Hz and 1250 Hz (Dt 1 increment ¼ 0.8 ms), respectively, to cover a similar range in ppm as the 7T study. Scan parameters, including timing (TE ¼ 18 ms, TR ¼ 2000 ms) and voxel size (8 mL), were otherwise kept identical to the 7T sequence and signal was acquired with a volumetric 32-channel head coil.
Human Volunteer Studies
All human studies were approved by the Institutional Review Board and this study was in compliance with the provisions of the Health Insurance Portability and Accountability Act (HIPAA). Written informed consent was obtained from all participants in the study.
One subject (age 31) was scanned seven times over 4 nonconsecutive days, and the L-COSY spectrum was acquired from the mid-occipital gray matter region to test the intrasubject reproducibility at 7T. A gradient-echo based localizer scan and a magnetization prepared rapid acquisition gradient echo (MPRAGE) sequence was acquired to facilitate the voxel placement. Each of these studies used 2.5 Â 2. As with the phantom study, the occipital lobe of one subject (age 46) was scanned using the same sequence on a 3T (Siemens Tim-Trio) scanner to compare in vivo signal quality between 3T and 7T. Scan parameters for the two field strengths were kept identical other than the reduction of F 2 , F 1 and water suppression bandwidths to accommodate the reduced spectral dispersion at 3T. The voxel size for the 3T study was 3.0 Â 3.0 Â 3.0 cm 3 (27 mL) . No outer volume suppression (OVS) was applied in any of the studies and management of lipid contamination was performed through careful voxel placement alone.
Two subjects (ages 31 and 46) underwent additional 2D L-COSY studies at 7T from the basal ganglia, frontal lobe, dorsolateral prefrontal cortex (DLPFC) and parieto-occipital region to evaluate the versatility of the 2D L-COSY sequence in obtaining spectra from locations further away from the isocenter of the magnet (occipital lobe) and the imaging coil. 
Postprocessing
The raw 2D L-COSY data extracted from the scanner was processed using a custom MATLAB-based postprocessing program (Version 7.0, The Mathworks, Natick, MA). In the first step of postprocessing, the program extracted and combined real and imaginary time-domain signal from the raw data file. This signal was scaled by a constant value and the spectral oversampling and dummy points were removed. The signal was then averaged in the time domain.
Coil combination was performed using a custom method that preserved phase information along the t 1 dimension, in contrast to the zero-phasing scheme implemented by the Siemens image calculation environment (ICE). This method facilitated the use of multi-channel coils in acquiring the 2D data. Following coil combination, data were zero-filled and spectral line-broadening filters were applied before Fourier transformation along both t 2 and t 1 time dimensions (24, 25) . A sinebell filter was applied along the t 1 dimension and a skewed-squared sinebell filter (skew parameter ¼ 0.3) along the t 2 dimension. The resulting two frequency dimensions (F 1 and F 2 ), were then plotted as magnitude-mode contour plots using MATLAB macros.
Using chemical shift information derived from the literature (21-23), diagonal and cross-peaks were assigned in the 2D spectra and quantified using a volume integral method (26), analogous to calculating peak areas in 1D MRS. Quantification regions were drawn around each identified peak and the total signal within these regions was calculated in magnitude mode. To avoid introducing measurement bias to the data, these regions were not moved from scan to scan, beyond an initial adjustment for center frequency using NAA as a reference at 2.0 ppm. Crosspeak integrals values were determined by averaging the signal of detectable cross-peaks above and below the diagonal. The reliability of the measurements was determined by calculating the coefficient of variation (CV) of the ratio between a given metabolite (standard deviation / mean) and the integral value of the Cr diagonal peak at 3.0 ppm (8) . This value will hereafter be referred to as the CV of S/S Cr .
RESULTS
The full width at half-maximum (FWHM) of the water signal in magnitude-mode 1D spectra for the phantom studies at 7T ranged between 5 and 7 Hz, while for the human studies it was 20-30 Hz. The water suppression scheme was generally very effective, with the residual peak of water showing a similar intensity as that of the NAA peak, indicating that over 99% of the water signal was suppressed. Water suppression resulted in the unavoidable partial suppression of the above diagonal cross-peaks of GSH at [F 2 , F 1 ] ¼ (2.9 ppm, 4.5 ppm) and NAA at [F 2 , F 1 ] ¼ (2.5 ppm, 4.3 ppm), because these resonances appear near the water peak at 4.7 ppm. Measurement of these metabolites therefore relied only on the quantification of the cross-peaks below the diagonal, which were clearly visible across all 7T studies because those peaks were unaffected by the water suppression. Figure 2 shows a representative 2D L-COSY spectrum from the brain phantom. Diagonal and crosspeaks are labeled. For the peak quantification scheme, the range of chemical shifts was outlined using rectangular boxes for each identified metabolite peak, and the volume of the signal was quantified within the selected region. All of the metabolites present in the phantom (Table 1) were detected in each study, including the peaks due to choline-containing compounds (Cho, phosphocholine (PC), phosphoethanolamine (PE) and ethanolamine (Eth)). GSH at [F 2 , F 1 ] ¼ (4.5 ppm, 2.9 ppm) was identifiable from the well-suppressed water signal and resonances due to lactate (Lac) were clearly identifiable in the phantom, which contained no lipids. Cross-peaks due to Glu [F 2 , F 1 ] ¼ (2.5 ppm, 2.1 ppm) and Gln [F 2 , F 1 ] ¼ (2.4 ppm, 2.0 ppm) were observed with a spectral separation of approximately 0.1 ppm, allowing differentiation between them due to the low line-widths observed (6) (7) (8) . Figure 3 shows a 2D L-COSY spectrum obtained from the occipital lobe of a healthy volunteer. Several diagonal and cross-peak resonances were identified in the 2D spectra. All of the metabolite resonances quantified in the phantom were also visible in the occipital lobe, with the exception of DSS at [F 2 , F 1 ] ¼ (3.1 ppm, 1.8 ppm), an external standard, which is not expected in the healthy brain. The diagonal peak of Lac at [F 2 , consequently not quantified in those studies, although the cross-peak of Lac at [F 2 , F 1 ] ¼ (4.1 ppm, 1.3 ppm) overlapping with that of Thr was quantified. The 2D cross-peaks due to the amino acids lysine (Lys) at [F 2 , F 1 ] ¼ (3.0 ppm, 1.7 ppm) and isoleucine (Ile) at [F 2 , F 1 ] ¼ (2.04 ppm, 0.95 ppm) were additionally detected in vivo from the human brain, which were not included in the brain phantom. Although GSH was detected in the L-COSY spectrum from all the human subjects, adjacent t 1 -ridging associated with the residual water signal appeared more prominent and closer to GSH in humans than with the phantom. T 1 -ridging associated with the peaks of Cho, Cr, and NAA also appears as vertical lines at F 2 ¼ 3.2, 3.0, and 2.0 ppm, respectively. Table 2 shows the CVs of S/S Cr from phantom studies at 3T and 7T. CVs for the brain phantom ranged from 2.5 to 6.6% in diagonal peaks and 6.2 to 20.0% in cross-peaks at 7T. The highest CV observed was from GABA at 15.6%. By contrast, CVs from the 3T study ranged from 7.9 to 11.2% for diagonal peaks and 7.9 to 119.3% for cross-peaks. A direct comparison of signal to noise ratio (SNR) indicated that most metabolite peaks were 2-3 times more intense at 7T compared with 3T. At 3T, Asp, Lac, and PC had an SNR of 2.7 or less and CVs of 23.6% or more, suggesting low signal intensity contributed to their CV. GABA also had a relatively high CV at 24.3% while GSH had the highest CV at 119.3% at 3T. GSH was unique in having a higher measured SNR at 3T, suggesting the quantification region was contaminated by the inconsistent presence of residual water signal. Table 3 shows the CVs of S/S Cr in both intrasubject and inter subject human brain studies at 7T. CVs for the human intrasubject study from the occipital lobe ranged from 6.1 to 9.5% in diagonal peaks and 4.6 to 21.7% in cross-peaks. The inter-subject variation study resulted in CVs from 4.3 to 14.3% in diagonal peaks and from 6.6 to 26.3% for cross-peaks. GABA, GSH, Tau and the choline-containing metabolites produced among the highest CVs measured in both the intrasubject (5.7 to 19.2%) and inter-subject studies (24.0 to 26.3%). In the 2D human brain spectra, glycerophosphocholine (GPC) and glycerophosphoethanolamine (GPE) appeared co-resonant with the cross-peaks of PC and PE, respectively, so peak quantification combined the intensity of those pairs of metabolite peaks. Figure 4 shows 2D spectra from the phantom as well as from the occipital lobe of the same subject at both 3T and 7T. The spectra were scaled such that the average noise in each spectrum would have identical intensity. The minimum contour threshold was selected to be just above the level at which background noise peaks would begin to appear in the spectra. Despite identical scan times and voxel sizes, spectra from the 7T scanner showed considerably better signal quality than their 3T counterparts. Consequently, cross-peaks due to Asp, GABA, GPC/PC, GPE/PE, Ile, Lac and mIþCho, all of which were clearly identifiable in the 7T spectra were weak, obscured or absent from the 3T spectra. Figure 5 shows a representative 2D spectrum acquired from the left basal ganglia of a healthy volunteer. The spectrum quality is similar to that observed in the reproducibility studies and demonstrates the same major diagonal and cross-peaks that were observed from the occipital lobe despite the smaller volume used. The quality of spectra from the parieto-occipital lobe, frontal lobe, and the dorsolateral prefrontal cortex (DLPFC, data not shown), also acquired with 15.6 mL voxels, were comparable to this spectrum.
DISCUSSION
In this study, we successfully demonstrated that the L-COSY sequence can reliably and reproducibly acquire 2D spectra from the brain at 7T. In addition, the sequence facilitated the unambiguous identification and quantification of cross-peaks from several metabolites, including GABA, Glu, Gln, GSH, Ile, Lys, and choline containing compounds, with increased separation than has been reported with the same sequence at lower field strengths of 1.5T or 3T (8, 27) . The ability to noninvasively detect these additional metabolites presents several applications with potential clinical utility. For example, 1D MRS studies have reported elevated total choline in tumors (28) and ex vivo studies with high resolution NMR have shown variations within the choline-containing metabolites, like higher PC/GPC ratio, correlating with high-grade gliomas (28) (29) (30) . High-resolution NMR has also been used to evaluate the concentration of Lys, Ile and other metabolites ex vivo in gliomas (29) , and these findings may serve as a guideline for the noninvasive monitoring of the biochemical changes observed in brain tumors. Elevated GABA (31-33) and reduced GSH synthesis (34) and dysfunctional glutamatergic neurotransmission (35, 36) have been implicated as markers for schizophrenia. Lys has been suggested as a biomarker for oxidative stress in nephropathy associated with Type II diabetes (37, 38) . The separation of Glu from Gln could have application in the field of neuropsychiatry as glutamatergic pathways have been suggested in the role of mood disorders (39, 40) such as bipolar disorder and major depression.
The results of the present study can most closely be compared with 2D L-COSY reproducibility studies in the brain at 1.5T and 3T (8, 27) . Both the previous studies used a voxel size of 3.0 Â 3.0 Â 3.0 cm 3 (27 mL) and 128 Dt 1 measurements for a total scan time of 34 min, with otherwise comparable scan parameters. At 1.5T, intersubject CVs ranged from 6-8% for diagonal peaks and 8-26% for cross-peaks while *Diagonal and cross-peaks are labeled as d and C, respectively. In the intersubject study, N refers to the number of subjects in the case of the intersubject study and the number of repeated scans of a single subject in the intrasubject study.
intrasubject cross-peaks ranged from 3-4% for diagonal peaks and 4-27% for cross-peaks. At 3T, intersubject CVs ranged from 5-19% for diagonal peaks and 8-35% for cross-peaks. Our results with equal or smaller voxel size and half the scan time suggest improved sensitivity in detecting these metabolites at 7T. In addition, a direct comparison between 3T and 7T showed several metabolites readily quantifiable at 7T that were difficult to separate from nearby resonances due to lower spectral dispersion (like GABA, GSH, and Lys), difficult to resolve from background noise due to lower SNR (like Ile, Lac, Asp) or some combination of the two. Spectra from 7T did show increased t 1 ridging compared with their 3T counterparts. These are visible as vertical lines especially around the diagonal peak resonances of Cho, Cr, NAA, and water and are likely due to scanner fluctuations, such as unstable RF amplification, table vibration or subject movement (41).
It is worth noting that, similar to our results, the cross-peaks of the choline-containing metabolites (Cho, GPC/PC, GPE/PE and Eth) generated the highest CVs in the occipital lobe in both 1.5T (13-26%, (27) ) and 3T (15% in occipital gray matter to 35% in occipital white matter, (8)) intersubject variation studies. The CVs for these metabolites in the phantom at 7T were considerably lower (7-13%), which may reflect a higher biological variation among these metabolites in humans as the age range of our human volunteers was from 30 to 72 years. CVs from intrasubject studies were generally lower than the corresponding CVs across different subjects at 1.5T and 7T (not measured in the 3T study), further suggesting the contribution of inherent variation to the intersubject CVs. Other metabolites with relatively higher CVs included GSH (not quantified at 1.5 T, 12-19% at 3T, 20-22% at 7T) and GABA (22-23% at 1.5T, not reported for 3T (8), 17-22% at 7T). The higher CV of GABA may be attributable to its relatively low concentration (below 1 mM in healthy brain and in the phantom). These previous studies agree with the direct comparison of 3T and 7T performed with the brain phantom reproducibility study, and show that 7T L-COSY was able to reliably detect more metabolites than 1.5T and 3T with CVs of the additionally detected metabolites comparable to those metabolites detectable at lower field strengths. The proximity of the residual water signal to the GSH peak ($0.1 ppm separation) suggests that variability in the effectiveness of water suppression may be a significant factor in the measurement of GSH, though the measurement of GSH was more stable at 7T than at 3T in the phantom studies.
The FASTESTMAP technique was used to facilitate higher-order shim corrections, resulting in acceptable water line-widths even in diverse brain anatomy such as the basal ganglia and DLPFC. Careful shimming and maintaining small voxel size is critical to reliable signal acquisition from difficult-to-shim regions like the DLPFC and hippocampus which are of particular interest in schizophrenia (33) . Multi-voxel-based MRSI sequences, using concentric circular echo-planar encoding or spiral encoding for faster acquisition, can facilitate smaller individual voxels by acquiring spectral data from a larger overall volume and higher spectral bandwidths at 7T (42, 43) .
Several limiting factors can contribute to the reliability of L-COSY at 7T. These include temporal instability due to field drift and imperfect shimming due to field inhomogeneity can affect line-widths and the effectiveness of water suppression. Human studies are subject to involuntary motion artifacts arising from the discomfort of a 17-min scan used in this study. Faster acquisition techniques, like averageweighting and nonuniformly under-sampled acquisition and compressed sensing reconstruction (44) could mitigate these artifacts to some degree and improve the clinical viability of the sequence while reducing patient discomfort. Changes in temperature or pH could make precise placement of measurement volumes difficult and this is a limitation of rigid measurement volumes. Prior knowledge fitting (ProFit) (45), a 2D prior-knowledge based fitting algorithm, requires the development of basis sets containing all the metabolites detectable at 7T, but could prove useful in mitigating these potential sources of error. Reproducibility studies of the human brain at 7T using LC-Model (46), a commonly used algorithm for quantitative analysis of 1D MRS, analogous to ProFit, demonstrated CVs under 20% for most 1D-detectable metabolites (41, 47) . 1D MRS at 7T with conventional localization and spectral editing found CVs under 20% for NAA, GluþGln (Glx), Cr, Cho, mI, and GSH but not for other metabolites such as Asp, GABA, Lac, PE, and Tau, where CVs ranged from 29.4-93.8% for PRESS and 26.7-63.6% for TE-Averaging methods (41) . The 1D MRS at 7T using very short echo times reported CVs ranging from 2.6 to 16.9% in the anterior cingulate and 3.4 to 44.1% in the dorsolateral prefrontal cortex (DLPFC). Neither of the 1D techniques at 7T reported detection or reliability measurements in Eth, Ile, or Lys (47).
In conclusion, this pilot study demonstrated the feasibility and reliability of 2D L-COSY in detecting additional metabolites in human brain than reported either by 1D studies at 7T or analogous 2D L-COSY studies at lower fields. Intersubject variation for quantified metabolite concentrations was in-line with variation of the same metabolites observed with this sequence at lower fields. Future development of the sequence will focus on improving scan performance, including both faster acquisition and smaller voxel size by implementing multi-voxel acquisition accelerated by concentric circular encoding based readouts. The 2D L-COSY sequence at 7T may aid in clinical applications including MRS studies in cancer and psychiatry where reliable detection and separation of individual choline containing compounds, separation of Lac from lipids, detection of Glu and GABA, could prove significant.
